main-logo

ICD-10 Code D75.821 | Non-immune heparin-induced thrombocytopenia Symptoms, Diagnosis, Billing

Non-immune heparin-induced thrombocytopenia is a condition characterized by a decrease in platelet count due to heparin exposure, without the involvement of an immune-mediated mechanism. It is clinically significant as it can lead to thrombotic complications and requires accurate diagnosis and documentation for effective management. The ICD-10 Code D75.821 facilitates precise coding for billing, clinical decision-making, and public health reporting.

What is ICD-10 Code D75.821 for Non-immune heparin-induced thrombocytopenia?

ICD-10 Code D75.821 represents Non-immune heparin-induced thrombocytopenia, a condition where platelet counts drop following heparin administration, not due to an immune response. This code is used in clinical documentation and billing when diagnosing patients experiencing thrombocytopenia related to heparin therapy, ensuring accurate representation of the patient's condition and facilitating appropriate treatment.

ICD-10 Code D75.821 – Clinical Definition and Explanation of Non-immune heparin-induced thrombocytopenia

Non-immune heparin-induced thrombocytopenia occurs when heparin induces a decrease in platelet counts through non-immune mechanisms, often leading to thrombotic events. It necessitates prompt medical evaluation and intervention to prevent complications. Understanding this condition is crucial for effective management and patient safety.

Key Clinical Features:

  • Thrombocytopenia following heparin exposure
  • Increased risk of thrombosis
  • Absence of anti-platelet antibodies
  • Potential for bleeding complications

ICD-10 Code D75.821 for Non-immune heparin-induced thrombocytopenia – SOAP Notes & Clinical Use

ICD-10 Code D75.821 is utilized in SOAP notes to document the clinical presentation, assessment, and management of patients with Non-immune heparin-induced thrombocytopenia. It plays a vital role in ensuring accurate symptom documentation and treatment planning in both acute and chronic care settings.

What Does ICD-10 Code D75.821 for Non-immune heparin-induced thrombocytopenia Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D75.821 connects subjective patient reports and objective clinical findings to a formal diagnosis of Non-immune heparin-induced thrombocytopenia. This code is essential for maintaining continuity of care, supporting accurate billing, and adhering to EHR documentation standards.

Treatment Options for ICD-10 Code D75.821 – Non-immune heparin-induced thrombocytopenia

Management of Non-immune heparin-induced thrombocytopenia requires immediate attention to prevent complications. Treatment strategies focus on discontinuing heparin and addressing thrombocytopenia.

Antibiotic Therapy:

  • Not applicable as this condition is not infectious

Supportive Care:

  • Monitor platelet counts regularly
  • Consider alternative anticoagulation if needed
  • Provide patient education on symptoms of thrombosis

Infection Control:

  • Not applicable as this condition is not infectious

How to Document Symptoms of Non-immune heparin-induced thrombocytopenia (ICD-10 D75.821) in SOAP Notes

Subjective:

  • Patient reports recent heparin exposure
  • Complaints of easy bruising
  • History of thrombosis or bleeding events
  • No known allergies to medications

Objective:

  • Platelet count significantly decreased
  • No signs of active bleeding on examination
  • Vital signs stable
  • Thrombotic events may be present on imaging studies
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Non-immune heparin-induced thrombocytopenia (ICD-10 Code D75.821)

Assessment:

  • Diagnosis: Non-immune heparin-induced thrombocytopenia, moderate severity
  • ICD-10 Code: D75.821
  • Common triggers include recent heparin therapy
  • Monitor for thrombotic complications

Plan:

  • Discontinue heparin immediately
  • Consider alternative anticoagulants
  • Educate patient on signs of thrombosis
  • Schedule follow-up for platelet monitoring

Treatment & Plan Section for ICD-10 Code D75.821 – Non-immune heparin-induced thrombocytopenia

  • Discontinue heparin therapy immediately
  • Consider alternative anticoagulants such as fondaparinux
  • Educate patients on recognizing symptoms of thrombosis
  • Regular monitoring of platelet counts and clinical status

Using ICD-10 Code D75.821 for Non-immune heparin-induced thrombocytopenia in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and clinical findings in SOAP notes
  • Use D75.821 in appropriate clinical settings, such as inpatient or outpatient care
  • Align treatment plans with clinical guidelines to support justified billing
  • Include relevant CPT codes that correspond to the services provided

ICD-10 Code D75.821 in Medical Billing and Insurance for Non-immune heparin-induced thrombocytopenia

ICD-10 Code D75.821 is crucial for billing purposes in hospital, ER, or infectious disease care settings, ensuring accurate representation of the patient's condition.

Billing Notes:

  • Document all relevant clinical findings and patient history to support the diagnosis
  • Use D75.821 in settings where heparin exposure is documented
  • Ensure that treatment plans are clearly outlined in the medical record

Common CPT Pairings:

CPT CodeDescription
36415Collection of venous blood by venipuncture
85025Complete blood count (CBC) with automated differential
99213Established patient office visit, level 3

Frequently Asked Questions

Common Questions About Using ICD-10 Code D75.821 for Non-immune heparin-induced thrombocytopenia

What are the common symptoms of Non-immune heparin-induced thrombocytopenia?

Common symptoms include easy bruising, petechiae, and potential bleeding complications. Patients may also experience thrombotic events, which can manifest as swelling or pain in the limbs.

How is Non-immune heparin-induced thrombocytopenia diagnosed?

Diagnosis is based on clinical history, particularly recent heparin exposure, along with laboratory findings showing a significant drop in platelet counts without evidence of immune-mediated mechanisms.

What treatment options are available for Non-immune heparin-induced thrombocytopenia?

Treatment primarily involves discontinuing heparin and considering alternative anticoagulants. Monitoring platelet counts and educating patients on recognizing symptoms of thrombosis are also essential.

Is Non-immune heparin-induced thrombocytopenia a serious condition?

Yes, it can lead to serious complications such as thrombosis, which may require urgent medical intervention. Prompt recognition and management are crucial.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved